About: XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.94 (-2.51%)
XBIT NASDAQ XBiotech Inc
XBiotech Inc share price
Atividade de preço de XBIT
Último preço
$ 1,940
Variação (24h)
-0,05 USD (2,51%)
Volume
73K
Volume (média 4 sem.)
-
Abertura
$ 1,98
Variação do dia
$ 1,87 - $ 1,98
Fechamento anterior
$ 1,99
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
XBIT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals